These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 31982325)

  • 21. Drug repurposing in rare diseases: Myths and reality.
    Fetro C; Scherman D
    Therapie; 2020 Apr; 75(2):157-160. PubMed ID: 32241561
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human Genetics: Questions, Challenges, and the Future.
    Cell; 2017 Oct; 171(2):259-260. PubMed ID: 28985554
    [No Abstract]   [Full Text] [Related]  

  • 23. Leveraging genetic data to investigate molecular targets and drug repurposing candidates for treating alcohol use disorder and hepatotoxicity.
    Gray JC; Murphy M; Leggio L
    Drug Alcohol Depend; 2020 Sep; 214():108155. PubMed ID: 32652377
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combinational Drug Repurposing from Genetic Networks Applied to Alzheimer's Disease.
    Nabirotchkin S; Bouaziz J; Glibert F; Mandel J; Foucquier J; Hajj R; Callizot N; Cholet N; Guedj M; Cohen D
    J Alzheimers Dis; 2022; 88(4):1585-1603. PubMed ID: 35811522
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systematic integration of biomedical knowledge prioritizes drugs for repurposing.
    Himmelstein DS; Lizee A; Hessler C; Brueggeman L; Chen SL; Hadley D; Green A; Khankhanian P; Baranzini SE
    Elife; 2017 Sep; 6():. PubMed ID: 28936969
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug Repurposing: A Network-based Approach to Amyotrophic Lateral Sclerosis.
    Fiscon G; Conte F; Amadio S; Volonté C; Paci P
    Neurotherapeutics; 2021 Jul; 18(3):1678-1691. PubMed ID: 33987813
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A machine learning and network framework to discover new indications for small molecules.
    Gilvary C; Elkhader J; Madhukar N; Henchcliffe C; Goncalves MD; Elemento O
    PLoS Comput Biol; 2020 Aug; 16(8):e1008098. PubMed ID: 32764756
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel drug candidate for the treatment of several soft‑tissue sarcoma histologic subtypes: A computational method using survival‑associated gene signatures for drug repurposing.
    Yang X; Huang WT; Wu HY; He RQ; Ma J; Liu AG; Chen G
    Oncol Rep; 2019 Apr; 41(4):2241-2253. PubMed ID: 30816547
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A survey of current trends in computational drug repositioning.
    Li J; Zheng S; Chen B; Butte AJ; Swamidass SJ; Lu Z
    Brief Bioinform; 2016 Jan; 17(1):2-12. PubMed ID: 25832646
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug Repurposing by Simulating Flow Through Protein-Protein Interaction Networks.
    Manczinger M; Bodnár VÁ; Papp BT; Bolla SB; Szabó K; Balázs B; Csányi E; Szél E; Erős G; Kemény L
    Clin Pharmacol Ther; 2018 Mar; 103(3):511-520. PubMed ID: 28643328
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Network-Based Drug Repositioning: Approaches, Resources, and Research Directions.
    Alaimo S; Pulvirenti A
    Methods Mol Biol; 2019; 1903():97-113. PubMed ID: 30547438
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathway analysis of GWAS loci identifies novel drug targets and repurposing opportunities.
    Jhamb D; Magid-Slav M; Hurle MR; Agarwal P
    Drug Discov Today; 2019 Jun; 24(6):1232-1236. PubMed ID: 30935985
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Network-based drug repurposing for schizophrenia.
    Truong TTT; Liu ZSJ; Panizzutti B; Kim JH; Dean OM; Berk M; Walder K
    Neuropsychopharmacology; 2024 May; 49(6):983-992. PubMed ID: 38321095
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Repurposing of Approved Cardiovascular Drugs against Ischemic Cerebrovascular Disease by Disease-Disease Associated Network-Assisted Prediction.
    Zhao QQ; Li X; Luo LP; Qian Y; Liu YL; Wu HT
    Chem Pharm Bull (Tokyo); 2019 Jan; 67(1):32-40. PubMed ID: 30404981
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transcriptomic Data Mining and Repurposing for Computational Drug Discovery.
    Wang Y; Yella J; Jegga AG
    Methods Mol Biol; 2019; 1903():73-95. PubMed ID: 30547437
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Unlocking hidden potential: advancements, approaches, and obstacles in repurposing drugs for cancer therapy.
    Weth FR; Hoggarth GB; Weth AF; Paterson E; White MPJ; Tan ST; Peng L; Gray C
    Br J Cancer; 2024 Mar; 130(5):703-715. PubMed ID: 38012383
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical Trials and Therapeutic Rationale for Drug Repurposing in Schizophrenia.
    Lago SG; Bahn S
    ACS Chem Neurosci; 2019 Jan; 10(1):58-78. PubMed ID: 29944339
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prioritization of candidate cancer drugs based on a drug functional similarity network constructed by integrating pathway activities and drug activities.
    Di J; Zheng B; Kong Q; Jiang Y; Liu S; Yang Y; Han X; Sheng Y; Zhang Y; Cheng L; Han J
    Mol Oncol; 2019 Oct; 13(10):2259-2277. PubMed ID: 31408580
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Network medicine for disease module identification and drug repurposing with the NeDRex platform.
    Sadegh S; Skelton J; Anastasi E; Bernett J; Blumenthal DB; Galindez G; Salgado-Albarrán M; Lazareva O; Flanagan K; Cockell S; Nogales C; Casas AI; Schmidt HHHW; Baumbach J; Wipat A; Kacprowski T
    Nat Commun; 2021 Nov; 12(1):6848. PubMed ID: 34824199
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Network mirroring for drug repositioning.
    Park S; Lee DG; Shin H
    BMC Med Inform Decis Mak; 2017 May; 17(Suppl 1):55. PubMed ID: 28539121
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.